Comment
Sepsis studies need new direction

https://doi.org/10.1016/S1473-3099(12)70136-6Get rights and content

References (8)

  • GR Bernard et al.

    Efficacy and safety of recombinant human activated protein C for severe sepsis

    N Engl J Med

    (2001)
  • Matsuyama K. Eisai's sepsis drug eritoran fails to save more lives in final-stage study....
  • D Annane

    Improving clinical trials in the critically ill: unique challenge—sepsis

    Crit Care Med

    (2009)
  • PM Klein Klouwenberg et al.

    Classification of sepsis, severe sepsis and septic shock: the impact of minor variations in data capture and definition of SIRS criteria

    Intensive Care Med

    (2012)
There are more references available in the full text version of this article.

Cited by (101)

  • Synthesis of bioactive lipid A and analogs

    2020, Recent Trends in Carbohydrate Chemistry: Synthesis and Biomedical Applications of Glycans and Glycoconjugates
View all citing articles on Scopus
View full text